Simon Amy sold BEAM
July 3, 2025 · Form 4 insider transaction
Simon Amy sold 876 shares of Beam Therapeutics Inc. at $20.12 per share, a transaction worth $17.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
876
Price
$20.12
Total value
$17.6K
InsiderSimon Amy
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 3, 2025
Filing dateJuly 3, 2025
Shares owned after64,864
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024.